These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33767999)

  • 1. GPER-Induced ERK Signaling Decreases Cell Viability of Hepatocellular Carcinoma.
    Qiu YA; Xiong J; Fu Q; Dong Y; Liu M; Peng M; Jin W; Zhou L; Xu X; Huang X; Fu A; Xu G; Tu G; Yu T
    Front Oncol; 2021; 11():638171. PubMed ID: 33767999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
    Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPER/ERK&AKT/NF-κB pathway is involved in cadmium-induced proliferation, invasion and migration of GPER-positive thyroid cancer cells.
    Zhu P; Liao LY; Zhao TT; Mo XM; Chen GG; Liu ZM
    Mol Cell Endocrinol; 2017 Feb; 442():68-80. PubMed ID: 27940299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
    Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
    Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY
    J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ER-mediated anti-tumor effects of shikonin on breast cancer.
    Yang Y; Gao W; Tao S; Wang Y; Niu J; Zhao P; Rao C; Yang L
    Eur J Pharmacol; 2019 Nov; 863():172667. PubMed ID: 31545985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.
    Wang RY; Chen L; Chen HY; Hu L; Li L; Sun HY; Jiang F; Zhao J; Liu GM; Tang J; Chen CY; Yang YC; Chang YX; Liu H; Zhang J; Yang Y; Huang G; Shen F; Wu MC; Zhou WP; Wang HY
    Gastroenterology; 2013 Dec; 145(6):1436-48.e1-12. PubMed ID: 23933603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis.
    Wei T; Chen W; Wen L; Zhang J; Zhang Q; Yang J; Liu H; Chen BW; Zhou Y; Feng X; Yang Q; Bai X; Liang T
    Cancer Lett; 2016 Nov; 382(2):195-202. PubMed ID: 27594673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma.
    Huang SZ; Wei MN; Huang JR; Zhang ZJ; Zhang WJ; Jiang QW; Yang Y; Wang HY; Jin HL; Wang K; Xing ZH; Yuan ML; Li Y; He XS; Shi Z; Zhou Q
    Front Oncol; 2019; 9():150. PubMed ID: 30931258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
    Shen Y; Yang F; Zhang W; Song W; Liu Y; Guan X
    Cell Physiol Biochem; 2017; 43(5):2047-2061. PubMed ID: 29059676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ER-α36/EGFR signaling loop promotes growth of hepatocellular carcinoma cells.
    You H; Meng K; Wang ZY
    Steroids; 2018 Jun; 134():78-87. PubMed ID: 29481815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells.
    Shen M; Shi H
    PLoS One; 2016; 11(3):e0151455. PubMed ID: 26982332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic monitoring of GPER-mediated estrogenic effects in breast cancer associated fibroblasts: An alternative role of estrogen in mammary carcinoma development.
    Luo H; Liu M; Luo S; Yu T; Wu C; Yang G; Tu G
    Steroids; 2016 Aug; 112():1-11. PubMed ID: 27016131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-Related Receptor α (ERRα) and G Protein-Coupled Estrogen Receptor (GPER) Synergistically Indicate Poor Prognosis in Patients with Triple-Negative Breast Cancer.
    Ye S; Xu Y; Wang L; Zhou K; He J; Lu J; Huang Q; Sun P; Wang T
    Onco Targets Ther; 2020; 13():8887-8899. PubMed ID: 33061416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular mechanism of apoptosis of breast cancer SKBR-3 cells induced by cryptanshinone via G protein coupled estrogen receptor( GPER) mediated pathway].
    Shi DN; Cui LX; Zhao PW; Sun LP; Chen M; Niu JZ
    Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(22):4905-4911. PubMed ID: 31872599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts.
    Pisano A; Santolla MF; De Francesco EM; De Marco P; Rigiracciolo DC; Perri MG; Vivacqua A; Abonante S; Cappello AR; Dolce V; Belfiore A; Maggiolini M; Lappano R
    Mol Carcinog; 2017 Feb; 56(2):580-593. PubMed ID: 27341075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
    Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
    Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-Protein-Coupled Estrogen Receptor Antagonist G15 Decreases Estrogen-Induced Development of Non-Small Cell Lung Cancer.
    Liu C; Liao Y; Fan S; Fu X; Xiong J; Zhou S; Zou M; Wang J
    Oncol Res; 2019 Feb; 27(3):283-292. PubMed ID: 28877783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
    Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
    Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.